BOSTON, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced a ...

Pyxis Tankers, a Nasdaq-listed owner of six midsize bulkers and tankers, has announced new financing agreements that free up cash it may invest in fleet expansion. The company announced late on Monday ...

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Pyxis Oncology, Inc. before investing. In this article, we go over a few key ...

MOL PLUS has decided to invest in Pyxis Maritime, a Singapore-based developer of electric vessels and operator of electric boat charging stations, as part of efforts to promote the commercialization ...

The Blackmagic Pyxis 12K takes the box-camera concept to another level, dropping the Ursa Cine 12K’s flagship sensor into a compact modular body. It may look like the 6K version, but its imaging is in ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

Pyxis Oncology ( (PYXS)) has provided an announcement. On December 18, 2025, Pyxis Oncology reported positive preliminary Phase 1 data for its first-in-concept antibody-drug conjugate MICVO in ...

The round is backed by Shift4Good, Motion Ventures, SG Growth Capital & Mol Plus Proceeds will be channelled towards scaling vessel production and advancing the Electra™ ecosystem Pyxis, a ...